DRIEHAUS CAPITAL MANAGEMENT LLC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-13 1:29 pm Sale | 2022-10-04 | 13G | Calidi Biotherapeutics, Inc. CLDI | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,667 4.840% | -6,667 (-80.00%) | Filing |
| 2022-10-11 08:55 am Sale | 2022-09-30 | 13G | Calidi Biotherapeutics, Inc. CLDI | DRIEHAUS CAPITAL MANAGEMENT LLC | 8,333 24.220% | -4,167 (-33.33%) | Filing |
| 2022-02-14 09:28 am Purchase | 2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | DRIEHAUS CAPITAL MANAGEMENT LLC | 12,500 5.220% | 12,500 (New Position) | Filing |